繁體
简体中文
繁體中文

Windward Bio Group WWB 深 滬

已收盤 11-20 16:00:00 美东时间

24.285

+0.275

+1.15%

华盛通華盛通
立即下載
  • 最 高26.20
  • 今 開23.71
  • 成交量 15.86万股
  • 最 低 22.43
  • 昨 收 24.01
  • 總市值 14.09亿
  • 52周最高 33.985
  • 市盈率 靜 --
  • 換手率 0.27%
  • 52周最低 18.35
  • 委 比 99.17%
  • 總股本 5803.87万
  • 歷史最高 33.985
  • 量 比 0.32
  • 振 幅 15.70%
  • 歷史最低 18.35
  • 每 手 1
  • 風險率 4.24%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • TJX Posts Strong Q3 Sales, Joins BellRing Brands, Bullish And Other Big Stocks Moving Higher On Wednesday

    U.S. stocks were mostly lower, with the Dow Jones index falling over 1% on Wednesday. Shares of TJX Companies Inc (NYSE:TJX) rose sharply after the company reported better-than-expected third-quarter sales results and raised its FY27 EPS guidance. TJX reported quarterly earnings of $1.34 per share w...

    11-18 23:59

  • Windward Bio to Participate at the Jefferies London Global Healthcare Conference

    Windward Bio Group AG (Nasdaq: WWB) announced that its management will present at the Jefferies London Global Healthcare Conference on November 18, 2026. A live and archived webcast of the presentation will be available on the company's website. Windward is a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for respiratory and dermatologic diseases. Its lead product, WIN378, targets TSLP and is being studied in...

    11-17 21:01

  • Innovative Immunology Biotech Windward Bio Lists on Nasdaq

    SHANGHAI, Nov. 14, 2026 /PRNewswire/ -- Windward Bio, a portfolio company of Qiming Venture Partners and a clinical-stage biotechnology company, successfully listed on Nasdaq on November 13,...

    11-14 11:13

  • Windward Bio Announces Pricing of Initial Public Offering

    Windward Bio Group AG announced the pricing of its initial public offering of 10,294,117 common shares at $17.00 per share, with a potential additional 1,544,117 shares via underwriters' option. The gross proceeds, including a concurrent private placement, are expected to be $225.0 million. The company also sold 1,532,691 common shares and pre-funded warrants worth $50.0 million to Sanofi Foreign Participations B.V. in a private placement. Windwa...

    11-12 23:18